Independent product profile
Puppy Dry Dog Food Rich in Turkey & Rice
Read the recorded recipe, market, intended use and review status below.
Product and intended use
Recorded editorial overview
This earlier overview is retained for context. Check the declarations and review status below before relying on its classification or suitability statements.
Puppy Dry Dog Food Rich in Turkey & Rice
Manufacturer declarations describe the label. EP interpretation and ingredient research do not establish the efficacy or suitability of this finished product.
Recorded declarations and sources
Puppy Dry Dog Food Rich in Turkey & Rice – Puppy Dry Dog Food Rich in Turkey & Rice
Maize
Rice (5.6%)
Oats (15.5%)
Chicken Fat (5%)
Omega Blend (Salmon Oil, Vegetable Oil & Linseed 1.8%)
Minerals
Seaweed (1000mg/kg)
FOS (1000mg/kg)
Yucca Extract (100mg/kg)
Fat Content 14%
Crude Fibre 3.5%
Crude Ash 8%
Omega 6 2.1%
Omega 3 0.3%
383 Kcal/100g
*7 Dried Turkey equivalent to 28g Turkey 5.6% Dried Rice equivalent to 14g of Rice & 1000mg/kg Dried Seaweed equivalent to 900mg of Seaweed, in every 100g Kibble
2-6 months old: 75-100g between 4 meals per day
6-12 months old: 82-110g between 3 meals per day
5-10kg
2-6 months old: 100-165g between 4 meals per day
6-12 months old: 110-185g between 3 meals per day
10-20kg
2-6 months old: 165-260g between 4 meals per day
6-12 months old: 185-310g between 3 meals per day
20-40kg
2-6 months old: 260-430g between 4 meals per day
6-12 months old: 310-525g between 3 meals per day
The checked date records when EP inspected or captured the source. It does not establish when the recipe changed. Calculations require verified values with a compatible basis and qualifiers.
Additional recorded source captures
- Recorded formulation source. EP checked: 2026-10-15. Capture scope: Declaration on the named formulation.
A source capture records the information available within that scope. It does not by itself complete label verification or establish product efficacy.
Manufacturer claims and evidence
These statements are attributed to the manufacturer. They are separate from EP interpretation and independently reviewed ingredient research.
Manufacturer claims have not been captured in this record
Ingredient research does not establish an effect of this finished product.
Explore ingredients and research
Reviewed ingredient links and research context appear here when available. Their presence does not establish an effect of this finished product.
Reviewed ingredient research context
These are reviewed ingredient connections for Puppy Dry Dog Food Rich in Turkey & Rice – Puppy Dry Dog Food Rich in Turkey & Rice. Direct describes an ingredient relationship, not proof for this commercial product. No ingredient study is treated as a test of this finished product.
FOS and MOS in dogs: digestion, microbes and immune markers
One study, 1 reviewed ingredient or arm connection(s).
Fructo-oligosaccharides (FOS); arm fos-supplement
Declared occurrence: FOS (1000mg/kg). Tested preparation: FOS supplied at 1 g per feeding, twice daily.. Population: Four adult female dogs with ileal cannulas; 14-day periods..
Study dose: 1 g per feeding, twice daily. Oral feeding supplement.. Duration: 14-day periods.. Comparator: The same kibble without these supplements..
Measured outcome: Digestibility, microbial populations, protein-breakdown products, and immune indices.. Finding within this study: FOS-containing treatments lowered faecal indoles and phenols. Combined FOS/MOS increased ileal IgA versus control; several reported effects were only trends.
Applicability and limitations: Very small, surgically instrumented population; short periods and multiple surrogate outcomes. Related papers may share experiments. Only for published UK dog products whose active formulation has a verified FOS ingredient line. This study tested a separate FOS supplement in four cannulated adult female dogs; it is ingredient context, not a finished-product or life-stage test. Preparation equivalence is not established by this declaration. Product inclusion quantity is not declared. A declared ingredient amount does not establish intake of the study dose. The formulation declaration is disputed or awaits label verification.
Abstract reviewed; source reviewed 2026-09-25.
Protein level changes the response to FOS in dogs
One study, 1 reviewed ingredient or arm connection(s).
Fructo-oligosaccharides (FOS); arm fos-in-protein-factorial
Declared occurrence: FOS (1000mg/kg). Tested preparation: Fructo-oligosaccharide (FOS) added to lower- and higher-protein foods; inclusion level not reported in the reviewed abstract.. Population: 12 healthy adult dogs in a replicated four-treatment Latin square..
Study dose: Not reported in the reviewed abstract. Food inclusion; amount not reported.. Duration: 28-day periods with washouts.. Comparator: Corresponding unsupplemented foods..
Measured outcome: Faecal fermentation, microbes, and apparent digestibility.. Finding within this study: Higher protein and FOS each increased faecal ammonia. FOS increased apparent digestibility of several minerals; protein level modified some FOS effects, including bifidobacteria and protein digestibility.
Applicability and limitations: Faecal measurements are surrogate outcomes. Small healthy population; no disease-treatment endpoint. Only for published UK dog products whose active formulation has a verified FOS ingredient line. The study tested FOS in different protein diets in healthy adult dogs; it is ingredient context, not a finished-product or life-stage test. Preparation equivalence is not established by this declaration. Product inclusion quantity is not declared. A declared ingredient amount does not establish intake of the study dose. The formulation declaration is disputed or awaits label verification.
Abstract reviewed; source reviewed 2026-09-25.
Source and review scope
Current sources, checked dates, unresolved conflicts and declaration coverage appear with each recorded formulation above. Source capture, label verification, ingredient matching and evidence appraisal are separate review steps.
Further source and evidence review remains pending